Immunopathogenesis of Sjögren's syndrome

@article{Borchers2003ImmunopathogenesisOS,
  title={Immunopathogenesis of Sj{\"o}gren's syndrome},
  author={Andrea T. Borchers and Stanley M. Naguwa and Carl L Keen and M. Eric Gershwin},
  journal={Clinical Reviews in Allergy \& Immunology},
  year={2003},
  volume={25},
  pages={89-104}
}
Sjögren's syndrome (SS) is an autoimmune disease characterized by the sicca symptoms of dry eyes and dry mouth. Glandular dysfunction is thought to arise from destruction associated with lymphocytic infiltration. The degree of glandular destruction, however, does not correlate with the severity of sicca symptoms, suggesting that other mechanisms are involved, including abnormalities in parasympathetic neurotransmission. Autoantibodies against the muscarinic acetylcholine receptor have been… 
Immunobiology of T Cells in Sjögren’s Syndrome
TLDR
This review comprehensively summarizes the research progress and the understanding of T cells in SjS, including CD4 + T cells, CD8 + T RM cells, and innate T Cells, to provide insights into for clinical treatment.
Histopathological and immunohistochemical profile in primary Sjögren's syndrome.
TLDR
Evaluating various autoimmune activity patterns present in salivary glands by means of immunohistochemistry (IHC) analysis identified both morphological changes, i.e., ductal system abnormalities or increased interstitial fibrosis, and immunological patterns associated with SS pathogenesis.
The Coexistence of Sjögren's Syndrome and Primary Biliary Cirrhosis: A Comprehensive Review
TLDR
Growing evidence supports in primary biliary cirrhosis and Sjogren syndrome the view that B cells, T cytotoxic cells, and T helper cells are involved in chronic inflammation, likely via the altered expression of pro-inflammatory cytokines.
Sjogren’s syndrome: Review of the aetiology, Pathophysiology & Potential therapeutic interventions
TLDR
The aetiology of Sjogren’s syndrome is reviewed, aspects that contribute to the pathophysiology of the disease are highlighted and treatment options that target different mediators of pathogenesis are explored.
Sjögren's Syndrome: Diagnosis and Management
TLDR
It is concluded that early diagnosis of Sjögren's syndrome is crucial to prevent and/or minimize potentially life-threatening complications.
What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?
Sjögren syndrome and MIG.
TLDR
An amelioration of autoimmune sialadenitis with MIG antagonists has been observed in experimental settings, suggesting a possible therapeutic approach to SS and more investigations are needed to assess whether MIG is a novel therapeutic target for SS in humans.
...
...

References

SHOWING 1-10 OF 103 REFERENCES
Chemokines and Cell Trafficking in Sjögren's Syndrome
TLDR
The identification over recent years of chemokines and their receptors enables us to address the specific processes involved in the migration of inflammatory cells into exocrine glands, the development of their secondary structures and patterns of retention within the glands and potentially the subsequent transformation of B cells into mucosa associated lymphoid tissue (MALT) lymphoma.
Sjögren’s Syndrome: Autoantibodies to Cellular Antigens
TLDR
Increased evidence of direct involvement of anti-Ro/SSA and anti-La/SSB autoantibodies in the pathogenesis of tissue injury has been contributed by several studies.
Sjögren's syndrome. Proposed criteria for classification.
TLDR
The clinical and laboratory features of patients referred for evaluation of sicca symptoms are reviewed, and the need for care in choosing the site for minor salivary gland biopsy is emphasized, and histologic features that aid in the evaluation of these biopsy specimens are described.
Antibodies to CD4 in primary Sjögren's syndrome.
TLDR
This is the first study that shows anti-CD4 antibodies in patients with primary Sjögren's syndrome, and the significance of these antibodies in the immunopathogenesis of Sj Ögren’s syndrome remains to be determined.
Analysis of TNFalpha microsatellites in 35 patients with primary Sjögren's syndrome.
TLDR
The data support a role for the TNFalpha10 allele in primary Sjögren's syndrome, particularly those forms with joint symptoms and anti-Ro(SS-A) antibodies.
Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome.
TLDR
Results suggest that Th1 cytokines, as well as IL-10, IL-6, and TGF beta, are essential in the induction and/or maintenance of SS, while Th2 cytokines are involved in the progression of the disease process, especially local B cell activation.
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome.
TLDR
The different types of B cell clonal expansion may imply a different risk of lymphoma progression and an accurate clinical, histopathologic, and molecular characterization may be crucial in future studies aimed at clarifying the pathobiology of SS-associated lymphoproliferation.
Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
TLDR
Autoantibodies that act as antagonists at M3-muscarinic receptors on smooth muscle occur in a subset of patients with primary and secondary SS, and appear to contribute to sicca symptoms and may explain associated features of autonomic dysfunction in some patients.
T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome.
TLDR
In this immunohistologic study of snap frozen minor salivary gland biopsies from 16 patients with primary Sjögren's syndrome, it was shown that the majority (77%) of the infiltrating T cells exhibit the memory helper/inducer phenotype (UCHL-1) and express LFA-1 molecules.
Prevention and Induction of Autoimmune Exocrinopathy Is Dependent on Pathogenic Autoantigen Cleavage in Murine Sjögren’s Syndrome1
TLDR
It is found that immunization with recombinant α-fodrin protein identical with an autoantigen into normal recipients induced autoimmune lesions similar to SS and that caspase inhibitors might provide a new therapeutic option directed at reducing tissue damage in the murine model for SS.
...
...